Global, regional, and national burden of brain and central nervous system cancer in children and adolescents, 1990–2021: A systematic analysis of the Global Burden of Disease study 2021
Open Access
- 11 September 2025
- journal article
- Published by Wiley in Pediatric Investigation
- Vol. 9 (4) , 325-336
Abstract
Importance: Brain and central nervous system (CNS) cancers are the most common pediatric solid tumors, significantly affecting the patients’ life expectancy and quality. Objective: To examine the disease burden of brain and CNS cancer in children and adolescents from 1990 to 2021 across various age groups, sexes, and socio‐demographic index levels, at the global, regional, and national levels. Methods: Data, including the incidence, mortality, and disability‐adjusted life years (DALYs) of brain and CNS cancer in children and adolescents, were obtained from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study. Temporal trends were evaluated using the Joinpoint regression model. The relationship between disease burden and socioeconomic development, as well as health inequality, was examined. Results: In 2021, the global age‐standardized incidence rate of brain and CNS cancers among patients aged 0–20 years was 1.55 per 100 000 population. From 1990 to 2021, the global age‐standardized mortality rate (ASMR) declined from 1.14 to 0.76 per 100 000, and the age‐standardized DALY rate (ASDR) decreased from 94.29 to 62.79 per 100 000. Over the past three decades, most regions and countries and territories have shown declining trends in ASMR and ASDR. Global inequality of disease burden persists, with regions possessing higher socioeconomic statuses exhibiting lower ASMR, ASDR, and mortality‐to‐incidence ratio. Interpretation: The decline in ASMR and ASDR of pediatric brain and CNS cancer indicates improvements in disease management and patient outcomes. Enhancing diagnostic and therapeutic strategies, improving life quality, and promoting health equity are crucial directions for future research.Keywords
This publication has 48 references indexed in Scilit:
- Sex-related incidence and survival differences in pediatric high-grade glioma subtypes: A population-based cohort studyiScience, 2023
- Global, Regional, and National Incidence and Mortality Trends in Pediatric Central Nervous System Tumors over the Past 2 DecadesWorld Neurosurgery, 2023
- Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatmentMed, 2022
- Brain Tumors in ChildrenNew England Journal of Medicine, 2022
- International patterns and trends of childhood and adolescent cancer, 1978-2012Journal of the National Cancer Center, 2022
- Imaging Advances for Central Nervous System TumorsHematology/Oncology Clinics of North America, 2022
- Incidence and survival of childhood central nervous system tumors in Denmark, 1997–2019Cancer Medicine, 2021
- Validated quantitative needs assessment differences in the management of children with central nervous system cancer between Brazil, an upper middle‐income country, and the United States of America, a high income countryPediatric Blood & Cancer, 2021
- Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United StatesPediatric Blood & Cancer, 2018
- Long-Term Cognitive Sequelae After Pediatric Brain Tumor Related to Medical Risk Factors, Age, and SexPediatric Neurology, 2014